Czech Medicine Spending Rises

4 September 1994

The Czech Ministry of health says medicines consumption reached 5 billion koruna ($178.5 million) by value in the first quarter of 1994, up 58% on first-quarter 1993, reports the Business News of the Czech CTK news agency. The start of 1994 was marked by a sharp rise in prescription numbers, putting the Czech republic first in Europe per capita.

Czech drug prices rose 7.5% in the quarter, while drugs imported from the Slovak Republic rose 6% and those from elsewhere were up 8%, says the agency. Since mid-July, a new system divides drugs into those paid for in full or part by insurance and those paid for by consumers, it adds.

Other reports from CTK Business News: - Czech production of drugs and chemicals rose 5% in the first half of 1994 over first-half 1993. Prices of medical and sanitary products rose only slightly during the period, with little change seen in prices from May to June.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight